Sreetama Dutt is a news curator and columnist at Immuno-Oncology News. She studied biotechnology at SRM Institute of Science and Technology, and did her Masters in medical microbiology at University of Manchester in Manchester, UK.
Xencor, a clinical-stage biotech company focussed on designing monoclonal antibodies for the cure of autoimmune diseases and cancer, has been developing several products via an innovative technology called XmAb, which uses ... Read more
April 21st, 2015 saw the launch of a major research based collaboration between Tokyo-based Astellas Pharma Inc. and Massachusetts based Potenza Therapeutics. The long term goal of this collaboration seeks ... Read more